These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26295951)

  • 1. Editorial: Emerging Formulation Design and Drug Delivery Systems for Inhaled Therapy.
    Chan HK; Zhou QT
    Curr Pharm Des; 2015; 21(27):3852-3. PubMed ID: 26295951
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Drug Delivery Australia.
    Skwarczynski M; Boyd BJ; Toth I
    Curr Drug Deliv; 2015; 12(1):2. PubMed ID: 25860965
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled Formulation Design for the Treatment of Lung Infections.
    Garcia-Contreras L; Yadav KS
    Curr Pharm Des; 2015; 21(27):3875-901. PubMed ID: 26290199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation, characterization, and fate of inhaled drug nanoparticles.
    Zhang J; Wu L; Chan HK; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery for optimised products: from product life-cycle management to first-generation product concepts.
    Bhatt PP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):1-2. PubMed ID: 16296731
    [No Abstract]   [Full Text] [Related]  

  • 6. Conference report: 1st Medicon Valley Inhalation Symposium.
    Lastow O
    Ther Deliv; 2013 Feb; 4(2):149-51. PubMed ID: 23343154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo testing methods for respiratory drug delivery.
    Agu RU; Ugwoke MI
    Expert Opin Drug Deliv; 2011 Jan; 8(1):57-69. PubMed ID: 21174605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.
    Lin YW; Wong J; Qu L; Chan HK; Zhou QT
    Curr Pharm Des; 2015; 21(27):3902-16. PubMed ID: 26290193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategy and collaboration between medicinal chemists and pharmaceutical scientists for drug delivery systems].
    Mano T
    Yakugaku Zasshi; 2013; 133(1):67-72. PubMed ID: 23292022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of developing palatable oral paediatric formulations.
    Cram A; Breitkreutz J; Desset-Brèthes S; Nunn T; Tuleu C;
    Int J Pharm; 2009 Jan; 365(1-2):1-3. PubMed ID: 18848611
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of challenges and opportunities in drug delivery and pharmaceutics.
    Panicucci R; Sanchez-Felix M
    Ther Deliv; 2015; 6(8):911-4. PubMed ID: 26305510
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the development of microparticles for pulmonary administration.
    Jain H; Bairagi A; Srivastava S; Singh SB; Mehra NK
    Drug Discov Today; 2020 Oct; 25(10):1865-1872. PubMed ID: 32712311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery.
    Hu X; Yang FF; Liao YH
    Curr Pharm Des; 2016; 22(17):2532-48. PubMed ID: 26818873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation.
    Sosnowski TR
    Curr Pharm Des; 2016; 22(17):2453-62. PubMed ID: 26818874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and fabrication of hydrogel-based nanoparticulate systems for in vivo drug delivery.
    Lai WF; He ZD
    J Control Release; 2016 Dec; 243():269-282. PubMed ID: 27746276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on pMDI and VHC; past, present, future!
    Amirav I
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S1-3. PubMed ID: 25054479
    [No Abstract]   [Full Text] [Related]  

  • 19. The dispersion behaviour of dry powder inhalation formulations cannot be assessed at a single inhalation flow rate.
    Grasmeijer F; de Boer AH
    Int J Pharm; 2014 Apr; 465(1-2):165-8. PubMed ID: 24548720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery.
    Lip Kwok PC
    Curr Pharm Des; 2015; 21(27):3945-54. PubMed ID: 26290198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.